Initial Experience of Diffusion-weighted Magnetic Resonance Imaging to Assess Therapeutic Response to Induction Chemoradiotherapy Against Muscle-invasive Bladder Cancer

Urology

Volumn 75, Issue 2, 2010, Pages 387-391

  Yoshida, Soichiro ^a   Koga, Fumitaka ^a   Kawakami, Satoru ^a   Ishii, Chikako ^b   Tanaka, Hiroshi ^b   Numao, Noboru ^a   Sakai, Yasuyuki ^a   Saito, Kazutaka ^a   Masuda, Hitoshi ^a   Fujii, Yasuhisa ^a   Kihara, Kazunori ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b Ochanomizu Surugadai Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CYSTECTOMY; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; EXTERNAL BEAM RADIOTHERAPY; FEASIBILITY STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MULTIPLE CYCLE TREATMENT; MUSCLE INVASIVE BLADDER CANCER; PRIORITY JOURNAL; RADIATION DOSE; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; DIFFUSION MAGNETIC RESONANCE IMAGING; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SMOOTH; NEOPLASM INVASIVENESS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 75349093217     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2009.06.111     Document Type: Article

References (29)

1. Housset M., Maulard C., Chretien Y., et al. Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study. J Clin Oncol 11 (1993) 2150-2157
2. Rodel C., Weiss C., and Sauer R. Trimodality treatment and selective organ preservation for bladder cancer. J Clin Oncol 24 (2006) 5536-5544
3. Shipley W.U., Kaufman D.S., Zehr E., et al. Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer. Urology 60 (2002) 62-67 discussion: 67-68
4. Chung P.W., Bristow R.G., Milosevic M.F., et al. Long-term outcome of radiation-based conservation therapy for invasive bladder cancer. Urol Oncol 25 (2007) 303-309
5. Tekes A., Kamel I., and Imam K. Dynamic MRI of bladder cancer: evaluation of staging accuracy. Am J Roentgenol 184 (2005) 121-127
6. Saksena M.A., Dahl D.M., and Harisinghani M.G. New imaging modalities in bladder cancer. World J Urol 24 (2006) 473-480
7. Dobson M.J., Carrington B.M., Collins C.D., et al. The assessment of irradiated bladder carcinoma using dynamic contrast-enhanced MR imaging. Clin Radiol 56 (2001) 94-99
8. Therasse P., Arbuck S.G., Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92 (2000) 205-216
9. Johnson R.J., Carrington B.M., Jenkins J.P., et al. Accuracy in staging carcinoma of the bladder by magnetic resonance imaging. Clin Radiol 41 (1990) 258-263
10. Yoshida S., Fujii Y., Yokoyama M., et al. A case of female urethral diverticular abscess clearly depicted by diffusion-weighted MRI. Int J Urol 15 (2008) 460-461
11. Koh D.M., and Collins D.J. Diffusion-weighted MRI in the body: applications and challenges in oncology. Am J Roentgenol 188 (2007) 1622-1635
12. Yoshida S., Masuda H., Ishii C., et al. Initial experience of functional imaging of upper urinary tract neoplasm by diffusion-weighted MRI. Int J Urol 15 (2008) 140-143
13. Matsuki M., Inada Y., Tatsugami F., et al. Diffusion-weighted MR imaging for urinary bladder carcinoma: initial results. Eur Radiol 17 (2007) 201-204
14. Abou-El-Ghar M.E., El-Assmy A., Refaie H.F., et al. Bladder cancer: diagnosis with diffusion-weighted MR imaging in patients with gross hematuria. Radiology 251 (2009) 415-421
15. Hamstra D.A., Rehemtulla A., and Ross B.D. Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology. J Clin Oncol 25 (2007) 4104-4109
16. Pickles M.D., Gibbs P., Lowry M., et al. Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 24 (2006) 843-847
17. Yankeelov T.E., Lepage M., Chakravarthy A., et al. Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Magn Reson Imaging 25 (2007) 1-13
18. Schubert M.I., Wilke M., Muller-Weihrich S., et al. Diffusion-weighted magnetic resonance imaging of treatment-associated changes in recurrent and residual medulloblastoma: preliminary observations in three children. Acta Radiol 47 (2006) 1100-1104
19. Moffat B.A., Chenevert T.L., Lawrence T.S., et al. Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci USA 102 (2005) 5524-5529
20. Hamstra D.A., Chenevert T.L., Moffat B.A., et al. Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci USA 102 (2005) 16759-16764
21. Hein P.A., Kremser C., Judmaier W., et al. Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study. Eur Radiol 45 (2003) 214-222
22. Dzik-Jurasz A., Domenig C., George M., et al. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet 360 (2002) 307-308
23. Kremser C., Judmaier W., Hein P., et al. Preliminary results on the influence of chemoradiation on apparent diffusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging. Strahlenther Onkol 179 (2003) 641-649
24. Koga F., Yoshida S., Kawakami S., et al. Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis. Urology 72 (2008) 384-388
25. Koga F., Kihara K., Fujii Y., et al. Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study. BJU Int 104 (2009) 189-194
26. Kageyama Y., Okada Y., Arai G., et al. Preoperative concurrent chemoradiotherapy against muscle-invasive bladder cancer: results of partial cystectomy in elderly or high-risk patients. Jpn J Clin Oncol 30 (2000) 553-556
27. Sobin L.H., and Wittekind C. TNM Classification of Malignant Tumours. 6th ed. (2002), Wiley-Liss, New York
28. Zietman A.L., Grocela J., Zehr E., et al. Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder. Urology 58 (2001) 380-385
29. Herr H.W. Transurethral resection of muscle-invasive bladder cancer: 10-year outcome. J Clin Oncol 19 (2001) 89-93